Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...
AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...
Hosted on MSN1h
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapyAmgen (NASDAQ:AMGN) and AstraZeneca (NASDAQ:AZN) announced Friday that their FDA-approved asthma therapy Tezspire reached ...
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...
The AstraZeneca PLC ADR AZN inched 0.01% higher to $71.43 Monday, on what proved to be an all-around grim trading session for ...
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
Investopedia on MSN2d
AstraZeneca Shares Slide As Execs in China Face Fraud InvestigationAstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback